OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
KIMMR$17.8957

Ersan Alisveris Hizmetleri ve Gida Sanayi Ticaret AS

Food Retail & DistributionVerified

Ersan Alisveris Hizmetleri ve Gida Sanayi Ticaret AS maintains a liquidity position with a current ratio of 1.18, indicating a moderate ability to meet short-term obligations. The company's liquidity FPT (free cash flow to total debt) is 0.16, suggesting that free cash flow is insufficient to cover total debt obligations. The price-to-book ratio of 1.49 and a debt-to-equity ratio of 0.59 indicate a relatively balanced capital structure, with equity playing a significant role in financing. Profitability metrics show a return on equity (ROE) of 12.24% and a return on assets (ROA) of 5.55%, which are key indicators of the company's efficiency in generating returns from equity and total assets. The gross profit margin is 22.56%, and the operating margin is 2.73%, both of which are below the industry median for Food Retail & Distribution, suggesting potential inefficiencies in cost management or pricing power. The company's revenue is primarily concentrated in Turkey, with no disclosed international operations. The business is not segmented by product or geographic region in the provided data, making it difficult to assess diversification or exposure to specific markets. The lack of segment reporting limits the ability to evaluate performance across different lines of business. Looking ahead, the company is expected to see a revenue growth of 4.5% in the current fiscal year and 3.2% in the next fiscal year. This growth is modest and aligns with the broader industry trends in the Food Retail & Distribution sector. The company's capital expenditure is negative, indicating a reduction in investment in physical assets, which may signal a focus on cost optimization or a shift in strategic priorities. The risk assessment highlights a medium liquidity risk, with a key flag indicating that net cash is negative after subtracting total debt. The dilution risk is low, and there are no immediate signs of equity dilution. The company has not issued additional shares recently, and there is no indication of a pending equity offering or share buyback program. Recent events and filings do not show any material changes in the company's operations or financial position. The company has not disclosed any significant legal proceedings, regulatory issues, or strategic shifts in the latest financial reports. The absence of recent events suggests a stable operational environment, but it also limits the visibility into potential future developments.

30-day price · KIMMR-1.79 (-9.5%)
Low$16.27High$19.05Close$16.98As of15 May, 00:00 UTC
Profile
CompanyErsan Alisveris Hizmetleri ve Gida Sanayi Ticaret AS
TickerKIMMR.IS
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryFood Retail & Distribution
AI analysis

Business. Ersan Alisveris Hizmetleri ve Gida Sanayi Ticaret AS operates in the food retail and distribution sector, generating revenue through the wholesale and retail sale of food and necessities, as well as the production and sale of meat and meat products.

Classification. The company is classified under the Consumer Non-Cyclicals economic sector, specifically in the Food & Drug Retailing business sector, with a high confidence level of 0.92.

Ersan Alisveris Hizmetleri ve Gida Sanayi Ticaret AS maintains a liquidity position with a current ratio of 1.18, indicating a moderate ability to meet short-term obligations. The company's liquidity FPT (free cash flow to total debt) is 0.16, suggesting that free cash flow is insufficient to cover total debt obligations. The price-to-book ratio of 1.49 and a debt-to-equity ratio of 0.59 indicate a relatively balanced capital structure, with equity playing a significant role in financing. Profitability metrics show a return on equity (ROE) of 12.24% and a return on assets (ROA) of 5.55%, which are key indicators of the company's efficiency in generating returns from equity and total assets. The gross profit margin is 22.56%, and the operating margin is 2.73%, both of which are below the industry median for Food Retail & Distribution, suggesting potential inefficiencies in cost management or pricing power. The company's revenue is primarily concentrated in Turkey, with no disclosed international operations. The business is not segmented by product or geographic region in the provided data, making it difficult to assess diversification or exposure to specific markets. The lack of segment reporting limits the ability to evaluate performance across different lines of business. Looking ahead, the company is expected to see a revenue growth of 4.5% in the current fiscal year and 3.2% in the next fiscal year. This growth is modest and aligns with the broader industry trends in the Food Retail & Distribution sector. The company's capital expenditure is negative, indicating a reduction in investment in physical assets, which may signal a focus on cost optimization or a shift in strategic priorities. The risk assessment highlights a medium liquidity risk, with a key flag indicating that net cash is negative after subtracting total debt. The dilution risk is low, and there are no immediate signs of equity dilution. The company has not issued additional shares recently, and there is no indication of a pending equity offering or share buyback program. Recent events and filings do not show any material changes in the company's operations or financial position. The company has not disclosed any significant legal proceedings, regulatory issues, or strategic shifts in the latest financial reports. The absence of recent events suggests a stable operational environment, but it also limits the visibility into potential future developments.
Key takeaways
  • The company maintains a moderate liquidity position with a current ratio of 1.18, but free cash flow is insufficient to cover total debt.
  • Profitability metrics, including ROE and ROA, are in line with industry standards, but gross and operating margins are below the median for the sector.
  • Revenue is concentrated in Turkey, with no disclosed international operations, and the company does not provide segment-level financial data.
  • Revenue growth is expected to be modest, with a 4.5% increase in the current fiscal year and 3.2% in the next fiscal year.
  • The company faces a medium liquidity risk, with net cash negative after subtracting total debt, but dilution risk is low.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyTRY
Revenue$9.43B
Gross profit$2.13B
Operating income$257.0M
Net income$351.0M
R&D
SG&A
D&A
SBC
Operating cash flow$674.3M
CapEx-$205.2M
Free cash flow$270.4M
Total assets$6.32B
Total liabilities$3.45B
Total equity$2.87B
Cash & equivalents$1.15B
Long-term debt$1.70B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$17.89
Market cap$4.27B
Enterprise value$4.82B
P/E12.2
Reported non-GAAP P/E
EV/Revenue0.5
EV/Op income18.7
EV/OCF7.1
P/B1.5
P/Tangible book1.5
Tangible book$2.87B
Net cash-$547.5M
Current ratio1.2
Debt/Equity0.6
ROA5.5%
ROE12.2%
Cash conversion1.9%
CapEx/Revenue-2.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food & Drug Retailing · cohort 234 companies
MetricKIMMRActivity
Op margin2.7%2.8% medp25 0.9% · p75 5.9%below median
Net margin3.7%1.8% medp25 0.3% · p75 3.6%top quartile
Gross margin22.6%24.1% medp25 13.8% · p75 31.4%below median
CapEx / revenue-2.2%-2.0% medp25 -3.8% · p75 -1.0%below median
Debt / equity59.0%56.0% medp25 14.0% · p75 113.8%above median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 09:39 UTC#11767b74
Market quoteclose TRY 17.89 · shares 0.24B diluted
no public URL
2026-05-10 09:39 UTC#9ff24561
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 09:41 UTCJob: d0bf89d4